Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: a case report

BACKGROUND: Chronic myeloid leukemia (CML) comprises ~3 % of pediatric leukemia. Although therapy with tyrosine kinase inhibitors (TKIs) is highly effective for CML, multiple factors have been identified as predictive of treatment failure. Chromosomal abnormalities involving the MECOM locus at 3q26...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomark Res
Asıl Yazarlar: Lewen, Margaret, Gresh, Renee, Queenan, Maria, Paessler, Michele, Pillai, Vinodh, Hexner, Elizabeth, Frank, Dale, Bagg, Adam, Aplenc, Richard, Caywood, Emi, Wertheim, Gerald
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4957483/
https://ncbi.nlm.nih.gov/pubmed/27453784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-016-0069-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller